SAN JOSE GASTROENTEROLOGY

Home | Sitemap | Contact Us

HUY NGOC TRINH, M.D., AGAF

Education and Training

  • Medical Doctor, Northwestern University School of Medicine, Chicago, Illinois 1982 - 1986
  • BS Chemistry Cum Laude, University of California, Berkeley, California 1977 - 1981

Post-Graduate Training

  • Fellowship in Gastroenterology, UC Irvine Medical Center, Orange, California 1989 - 1991
  • Residency in Internal Medicine, UCLA/VA Wadsworth Medical Center, Los Angeles, California 1986 - 1989
  • Internship in Internal Medicine, UCLA/VA Wadsworth Medical Center, Los Angeles, California 1986-1987

Present Status and Professional Activities

  • Active Medical Staff at Regional Medical Center of San Jose and O‘Connor Hospital since 1991.
  • Co-founder, President and CEO, Northern California Medical Advantage Medical Group - multi-specialty Independent Physician Association comprised of more than 150 physician members, founded in 2010
  • Co-founder and President, San Jose Gastroenterology, Medical Corporation, San Jose, California – single-specialty of gastroenterology medical group comprised of 6 gastroenterologists and one physician assistant, established since 2005
  • Founder, President and Medical Director, Montpelier Surgery Center, Inc., San Jose, California – Endoscopy center comprised of 6 gastroenterologists, established since 2001
  • Co-founder, President and Medical Director, Advanced Surgery Center, LP, San Jose, California – multi-specialty outpatient surgery center comprised of 22 surgeons, established since 2004
  • Co-founder and CMO, Liquid Medical Office, Inc., San Jose, California – software company developing complete electronic medical records for small physician practices, founded in 2009
  • Co-founder and Board Member, Pacific Health Foundation, Inc. – non-profit organization with mission to improve patient care through clinical investigation and education programs for physicians and patients, founded in 2003
  • General Partner, Pacific Health Consortium, LLC, founded in 2008
  • Co-founder and Program Director, Annual Liver Symposium, San Jose, California, CME program educating physicians and health care providers in liver diseases, established since 1994
  • Co-founder and Editor-in-Chief, Song Manh, Inc. – non-profit organization with mission to enhance Vietnamese  awareness of health, health care, education and family issues, with the belief that such knowledge is the foundation for better health and better quality of life, founded in 1995.

Certification and Licensure

  • Diplomate, American Subspecialty Board of Gastroenterology since 1991; Recertified 2002
  • Diplomate, American Board of Internal Medicine since 1989
  • California Licensed Physician - License # G061514 since 1987
  • Diplomate, National Board of Medical Examiners since 1987

Past Activities

  • Chair, GI Division, Regional Medical Center, San Jose, California 2004-2009
  • Member, Board of Directors, American Cancer Society, Santa Clara County 2003-2006
  • Member, Advisory Board, American Liver Foundation, Northern California Chapter 2003-2005
  • Clinical Instructor, Gastroenterology Division, Stanford University 1991-2003
  • Member, Board of Trustees, Columbia Regional Medical Center of San Jose 1999-2000
  • Founder, President and CEO,  Premier Care Medical Group of  Northern California 1995-1999
  • Alternate delegate, California Medical Association 1996-1998
  • Board of Director and General Secretary, Vietnamese Physician Association of  Northern California 1994-1996
  • Co-Chair, Committee for Young Professionals, 1995 International Convention of the Vietnamese Physicians, Dentists, and Pharmacists of the Free World June 1995
  • Member, Medical Care Committee, Regional Medical Center of San Jose 1994-present
  • Utilization Reviewer, Regional Medical Center of San Jose 1994-1996
  • Member, Quality Assurance Committee, Regional Medical Center of San Jose 1994-1996
  • Board of Director, Physicians Medical Group of  San Jose 1994-1995
  • President of Resident and Intern Association, VA Wadsworth 1988-1989

Invited Speaker

  • Electronic Medical Records for Physicians, Grand Round, O’Connor Hospital, San Jose, May 10, 2009
  • Hepatitis B Update, Grand Round, O’Connor Hospital, San Jose, April 10, 2009
  • Hepatitis B Update and Hepatocellular Carcinoma Treatment – Bach Mai Hospital and University of Ha Noi, School of Medicine, Ha Noi, February 10, 2009
  • Hepatitis B Update, Grand Round, Regional Medical Center of San Jose, Februray 5, 2009
  • Hepatocellular Carcinoma Evaluation and Treatment. The 6th International Convention of Vietnamese Physicians, Dentists and Pharmacists of the Free World 2008, San Jose, California, August 2008.
  • Hepatitis B Treatment Update. Hoan My Hospital System. Ho Chi Minh, Vietnam, June 18, 2008
  • Evaluation and Interpreting of Hepatitis B Results. American Liver Foundation. San Francisco, March 2008
  • Update Treatment of Hepatitis B. Hoan My Hospital System. Ho Chi Minh, Da Nang, Can Tho, December 2007
  • Frontline Management of chronic hepatitis B. Asian Health Foundation. San Jose, October 10, 2007
  • Hepatitis B Update, Vietnamese Physician Association, Northern California, San Jose,  September 2, 2007
  • An Evidence-Based Approach to the Management of HBV Infection, San Jose, March 1, 2007
  • Hepatitis B Update, Vietnamese Physician Association of USA, Dallas, November 4, 2006
  • Colon Cancer Screening Update, Weekly grand round, Regional Medical Center of San Jose, May 2006
  • Make Your Mark: the  Art of Treating Chronic Hepatitis B. San Jose, September, 2005
  • Hepatitis B Update; Vietnamese Physicians Association of Northern California. San Jose, September 2005
  • Colon Cancer Screening Vietnamese Physicians Association of Northern California. San Jose, May 2005
  • Update in Hepatitis B. San Jose, April 2005
  • Faculty and speaker: CD Rom Breaking the Cycle: HBV in Asian Americans.  New York, April 2005.
  • Organizer and Faculty Complex Liver Disease Symposium California Pacific Medical Center & Liver and Digestive Health Medical Clinic Half Moon Bay, CA, August 2004
  • Co-Chair and Faculty, Vietnamese Advisory Board for Viral Hepatitis, Santa Monica, CA, July 2004
  • Screening for Liver Cancer and Liver Diseases in Asian-Americans, KTSF Channel 36,Vietnamese Journal Program, San Francisco, CA, October 2003
  • Complications of Chronic Hepatitis B, Liver Symposium for Vietnamese Patients in Santa Clara County, San Jose, CA, April 2003
  • Viral Hepatitis B and C: The Vietnamese endemic, Channel 36: Dien Dan VietNam, San Francisco, CA, April 2003
  • Co-Chair and Faculty Liver Meeting California Pacific Medical Center and Liver And Digestive Medical Clinic Sonoma, July 2003
  • Colon Cancer Screening: Who and How, Channel 36: Dien Dan VietNam, San Francisco, CA, September 2002
  • Viral Hepatitis B, Weekly Grand Round, San Jose Medical Center, San Jose, CA, 2001
Viral Hepatitis B, Weekly Grand Round, Regional Medical Center of San Jose, San Jose, CA, 2001

Education and Community Service

  • Chair, Special Section Hepatitis B CME. The 6th International Convention of Vietnamese Physicians, Dentists and Pharmacists of the Free World 2008, San Jose, California, August 2008.
  • Ad promotion of hepatitis B in Vietnamese media. Health is Gold. 2008
  • “Aim for the B” Patient Workshop. Hepatitis B Foundation. San Jose, May 2007
  • Hepatitis B Advocacy. Los Angeles, May 2006
  • Make Your Mark: the Art of Treating Chronic Hepatitis B. San Francisco, September, 2005
  • “Aim for the B” Patient Workshop. Hepatitis B Foundation. San Jose, May 2005
  • Volunteer Faculty in Gastroenterology , Santa Clara Valley Medical Center/Stanford University 1991-2001
  • Board of Directors American Cancer Society, Santa Clara County 2003-2006
  • Editor-in-Chief Song Manh magazine 1995-present
  • Program Director and Faculty Annual Liver Symposium San Jose 1999-present
  • Chairman and Faculty Annual Vietnamese Health Fair San Jose 1999-Present
  • Advisory Board Member American Liver Foundation, Northern California Chapter 2001-2003     
  • Co-Chair, Committee for Young Professionals, 1995 International Convention of the Vietnamese Physicians, Dentists, and Pharmacists of the Free World San Jose, CA, June 1995
  • Board of Director, Physicians Medical Group of San Jose 1994-1995
  • Member, Board of Trustees, Columbia Regional Medical Center of San Jose 1999-2001
  • Founder, President and CEO,  Premier Care Medical Group of  Northern California 1995
  • President and CEO, Premier Care Medical Group of Northern California, 1995-1999
  • Alternate delegate, California Medical Association 1996-1998
  • Board of Director and General Secretary, Vietnamese Physician Association of Northern California  1994-1996

Current Research

  • Hepatitis B virus reverse transcriptase mutations were not detected in treatment-naïve patients with chronic hepatitis B using INNO LiPA HBV DR3: a prospective multicenter study.
  • Prevalence, risk factors, and disease knowledge of chronic hepatitis B (CHB) infection in Vietnamese Americans in California: A prospective study.
  • Treatment efficacy of entecavir (ETV) therapy in patients previously treated with adefovir (ADV): Interim report for a multicenter study
  • A Comparative study of chronic hepatitis B subjects treated with Entecavir plus Tenofovir combination vs Entecavir monotherapy in adults who are treatment-naïve to Nucleosides and Nucleotides: The BELOW study.  International multicenter study.
  • A Prospective, Randomized trial to investigate the effect of continued Adefovir versus Combination regimes of Telbivudine plus Adefovir, and Telbivudine plus Tenofovir In Patients with Chronic Hepatitis B and Suboptimal Viral Suppression (PROACTIV Study).  Multicenter study.
  • A randomized, double-blind, controlled evaluation of Tenofovir DF versus Adefovir Dipivoxil for the treatment of presumed Pre-core mutant chronic hepatitis B.  International multicenter study
  • A randomized, double-blind, controlled evaluation of Tenofovir DF versus Adefovir Dipivoxil for the treatment of wild type chronic hepatitis B. International multicenter study
  • Hepatitis C as an important etiology for hepatocellular carcinoma in Vietnamese Americans: retrospective cross-sectional study from 1992-1999.  Location: San Jose Gastroenterology, San Jose, CA, 2002-current. 
  • Prevalence and treatment outcomes of hepatitis C novel genotypes in Vietnamese: retrospective study of period 2000-2003.   Location: San Jose Gastroenterology, San Jose, CA, 2003-current.

Past Research

  • Risk Factors for Hepatocellular Cancer in U.S. Patients with Chronic Liver Disease Dr. E. Keefe, Dr. M. Nguyen, Dr. R. Cheung, Dr. H. Trinh. April 2002
  • A Phase 3 study of the Safety and Antiviral Activity of Entecavir vs. Lamivudine in Adult Patients with Chronic Hepatitis B who are Positive for Hepatitis E Antigen (Bristol Squibb Myers)
  • A Phase 3 study of the Safety and Antiviral Activity of Entecavir vs. Lamivudine in Adult Patients with Chronic Hepatitis B who are Negative for Hepatitis E Antigen (Bristol Squibb Myers)
  • A Phase 3 study of the Safety and Antiviral Activity of Entecavir vs. Lamivudine in Adult Patients with Chronic Hepatitis B who have an Incomplete response to Current Lamivudine Therapy (Bristol Squibb Myers)
  • Use of PegInterferon Alfa-2b and Ribavirin for Treatment of Patients with Chronic Hepatitis C with Normal ALT Levels
  • Study of Long Term PegIntron vs. Colchicine For Patients Who Have Failed to Respond to Rebetron/Interferon with Advanced Fibrosis and Cirrhosis Secondary to Hepatitis C Infection
  • A Phase 3 Partially Double Blinded Study Evaluating The Efficacy And Safety of Pegasus With Placebo Or Lamivudine Vs. Lamivudine in Hepatitis BE Ag Positive Patients With Chronic Hepatitis B (Roche)
  • Daily induction Intron-A and combination of Intron A and Ribavirin for treatment of chronic hepatitis C in patients with genotype 1
  • A Randomized, Double-Blind Study to Evaluate the Safety and Antiviral Activity of Three Doses of FTC in Patients Chronically Infected with Hepatitis B Virus
  • A Randomized-Controlled Study of the Effects of Treatment of Hepatitis C Virus by Alfa- Interferon
  • Administered either Daily for 6 Weeks or Daily for 12 Weeks.
  • A Randomized-Controlled Study of the Effects of Treatment of Hepatitis C Virus by Alfa- Interferon
  • Administered either Daily or Three Times a Week on a Vietnamese Population
  • Omeprazole Action on Acid Secretion and Serum Gastrin Responses in Man: Comparison with Ranitidine

  • Publications

  • Ha NB, Ha NB, Garcia RT, Trinh HN, Chaung KT, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH. Medication nonadherence with long-term management of patients with hepatitis B e antigen-negative chronic hepatitis B. Dig Dig Sci 2011. In Press.
  • Edward S, Trinh HN, Nguyen TT, Do ST, Phuong T, Nguyen HA, Nguyen KK, Garcia RT, Nguyen MH. High rate of complete viral suppression with entecavir therapy in patients with chronic hepatitis B and partial response to adefovir. Aliment Pharmacol Ther 2011. In Press.
  • Lam KD, Trinh HN, Do ST, Nguyen TT, Garcia RT, Nguyen T, Phan QQ, Nguyen HA, Nguyen KK, Nguyen LH, Nguyen MH. Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naïve chronic hepatitis C genotype 6. Hepatology 2010; 52(5): 1573-80.
  • Nguyen NH, Vutien P, Garcia RT, Trinh H, Nguyen H, Nguyen K, Levitt B,  Nguyen MH.  Response and tolerability to pegylated IFN and ribavirin in Asian Americans with chronic hepatitis C genotypes 1, 2/3, and 6. J Viral Hepat 2009. *In press. *
  • Nguyen MH, Garcia RT, Trinh HN, Nguyen HA, Nguyen KK, Nguyen LH, Levitt B.  Prevalence of baseline HBV DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B.  Aliment Pharmacol Ther 2009; 30:1150-1158.
  • Wong CR, Garcia RT, Trinh HN, Lam KD, Ha NB, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH. Adherence to screening for hepatocellular carcionma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci 2009; 54: 2712-2721
  • Nguyen LH, Ha NB, Vutien P, Ha NB, Garcia RT, Trinh HN, Levitt BS, Nguyen HA, Nguyen KK, Keeffe EB, Nguyen MH.  Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B. Hepatol Int 2009; 3:461-467.
  • Mindie H. Nguyen, Ruel T. Garcia, Huy N. Trinh, Khoa D. Lam, Gerald Weiss, Huy A. Nguyen, Khanh K. Nguyen, Emmet B. Keeffe.  Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA, and Normal Alanine Aminotransferase Levels.  American J. Gastroenterology 2009
  • Nghi B. Ha, Nghiem B. Ha, Ruel T. Garcia, Huy N. Trinh, Andrew A. Vu, Huy A. Nguyen, Khanh K. Nguyen, Brian S. Levitt, Mindie H Nguyen. Renal Dysfunction in Chronic Hepatitis B Patients Treated with Adefovir Dipivoxil.  Hepatology, 2009; 50:727-734.
  • Marcellin P, Jealthcote J, Buti M, Man Robert, Krastev Z, Germanidis G, Lee S, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman M, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F. Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for Chronic Hepatitis B. N Engl J Med 359;23, 2442-2455;2008
  • G. Nguyen, R.T. Garcia, N. Nguyen, H. Trinh, E.B. Keefe, M.H. Nguyen.  Clincal Course of Hepatitis B Virus Infection during Pregnancy.  Alimentary Pharmacology & Therapeutics 29, 755-764;2008
  • Khoa D. Lam, Ruel T. Garcia, Long H. Nguyen, Huy N. Trinh, George Triadafilopoulos, Jeanine T. Phan, Khanh Nguyen, Huy Nguyen, Aijaz Ahmed, Mindie H. Nguyen.  Prevalence of Colorectal Neoplasm in Asian Americans. Dig Dis Sci, 2008.
  • Nguyen Mindie, Trinh HN, Garcia R, Nguyen Gloria, Lam Khoa, Keeffe E. Higher Rate of Sustained Virologic Response in Chronic Hepatitis C Genotype 6 Treated with 48 Weeks Versus 24 Weeks of Peginterferon Plus Ribavirin.  Am J Gastroenterology 2008;103:1131-1135
  • Tsang P, Trinh HN, Garcia RT, Phan J, Ha N, Nguyen H, Nguyen K, Keeffe B E, Nguyen M.  Clinical Hepatology 2008. Significant Prevalence of Histologic Disease in Patients with Chronic Hepatitis B and Mildly Elevated Serum Alanine Aminotransferase Levels. Clinical Gastroentology and Hepatology 2008, 6:569-574. 
  • Safety and antiviral activity of emtricitabine (FTC) for the Treatment of Chronic Hepatitis B infection: A two-year Study. Gish R, Trinh H, Leung N, Chan F, Fried M, Wright T, Wang C, Anderson J, Mondou E, Snow A, Sorbel J, Rousseau F, Corey L. Journal of Hepatology 43 (2005) 60-66.
  • Lam KD, Phan J, Garcia RT, Trinh HN, Nguyen H, Nguyen K, Tradafilopoulos G, Vutien P, Nguyen M.  Low Proportion of Barrett’s Esophagus in Asian Americans. American J Gastroenterology 103: 1-6; 2008. In press
  • Nguyen MH, Trinh HN, Garcia RT, Vien P, Keeffe EB.  Hepatitis C is a major etiology for HCC in Vietnamese Americans.  Am J Gastroenterol 2004.  In press.
  •  “Unsedated ultrathin EGD is well accepted: A multicenter randomized trial and cost analysis of unsedated ultrathin EGD vs. sedated conventional EGD” Garcia RT, Cello JP, Nguyen MH, Rogers SJ, Rodas A, Trinh HN, Stollman N, McQuaid KR . Gastroenterology 2003; 125:1606-1612.
  • “Evaluation and Outcomes of Combination Therapy with Interferon or Pegylated Interferon and Ribavirin in a Cohort of 67 Southeast Asian Patients with Hepatitis C Genotypes 6, 7, 8, and 9” Nguyen MH, Trinh HN, Garcia RT, Ning J, Keeffe EB. [Abstract]. Hepatology 2003.
  • “Epidemiology of Hepatitis B and Hepatitis C in Asian Americans: Results of a Community-Based Cross-Sectional Study of 1355 Patients” Nguyen MH, Ning J, Garcia RT, Keeffe EB, Trinh HN. [Abstract].
  • “A Dose Ranging Study of the Pharmacokinetics, Safety, and Preliminary Antiviral Activity of Emtricitabine in Adults With HBV Infection”. Gish RG, Leung NWY, Wright TL, Trinh Huy, Lang W, Kessler HA, Fang L, Wang LH, Delehanty J, Rigney A, Mondou E, Sykes A, and Rousseau F.  Antimicrobial Agents and Chemotherapy, In Press, June 2002; Volume 46(6)
  • “Evidence for Carrier-Mediated Transport of Glutathione Across the Blood-Brain Barrier in the Rat” Ram Kannan, John F. Kuhlenkamp,  Eric Jeandifrer, Huy Trinh, Murad Ookhtens, Neil Kaplowitz.  Journal Clinical Investigation, Vol. 85, 2009-2013, June 1990.
  • “An Open Multicenter Study to Evaluate the Effect and Safety of Omeprazole 40mg IV on Intragastric pH in ICU patients”.  G. Vandeventer, B. Hirshowitz, W. Peterson, H. Trinh, B. Sytnik, B. Lamont, T. Humphries.  Abstract in Am. J. Gas., Sep. 1988, Vol. 83, Number 9, and 1041.
  • Trinh, HN.  Viral Hepatitis A, B, C. October 1999. Handbook of viral hepatitis in Vietnamese.

Abstracts

  • Chaung KT, Ha NB, Trinh HN, Ha NB, Garcia RT, Nguyen HA, Nguyen KK, Garcia G, Ahmed A, Keeffe EB, Nguyen MN. High rate of recurrent hepatitis B viremia following treatment-induced hepatitis B e antigen (HBeAg) seroconversion. Gastroenterology 2011; 140 (Suppl 1): S897. Oral presentation, Digestive Disease Week, Chicago, Illinois, May 2011.
  • Lin B, Ha NB, Liu A, Trinh HN, Nguyen HA, Nguyen KK, Garcia RT, Ahmed A, Garcia G, Keeffe EB, Nguyen MH. Incidence and predictors of hepatitis B e antigen (HBeAg) seroconversion in chronic hepatitis B (CHB) patients treated with anti-HBV therapy in routine clinical practice. Gastroenterology 2011; 140 (Suppl 1): S913.
  • Liu A, Ha NB, Lin B, Yip B, Trinh HN, Nguyen HA, Nguyen KK, Ahmed A, Garcia G, Keeffe EB, Nguyen MH. Incidence of hepatitis B e antigen (HBeAg) seroconversion and suboptimal response in chronic hepatitis B (CHB) patients treated with entecavir 0.5 mg daily in routine clinical practice. Gastroenterology 2011; 140 (Suppl 1): S931-932.
  • Nguyen V, Ha NB, Trinh HN, Nguyen HA, Nguyen KK, Garcia RT, Levitt BS, Nguyen MH. Long-term treatment response to entecavir and adefovir in treatment-naïve chronic hepatitis B e antigen-negative patients in a community setting. Gastroenterology 2011; 140 (Suppl 1): S933.
  • Nguyen MH, Trinh HN, Do ST, Tran PL, Nguyen TT, Nguyen KK, Nguyen HA, Garcia RT. Rapid complete viral suppression (CVS) with entecavir (ETV) in adefovir (ADV)-experienced patients: Interim report for a multicenter study. Gastroenterology 2011; S934.
  • Nguyen MH, Trinh HN, Garcia RT, Nguyen HA, Levitt BS, Keeffe EB, Cooper AD, Nguyen KK, Ayoub W, Daugherty T, Ahmed A. Hepatitis B virus (HBV) reverse transcriptase mutation prevalence was low in treatment-naïve patients with chronic hepatitis B (CHB) using INNO-LiPA HBV DR3 in a prospective multicenter study. Gastroenterology 2011; S973.
  • Ristau JT, Zhang S, Trinh HN, Garcia RT, Nguyen HA, Nguyen KK, Nguyen MH. Proportion of patients who were previously ineligible for anti-HBV therapy who became eligible after 12 months of follow-up: application of U.S. Panel and AASLD Guidelines. Gastroenterology 2011; S896. Oral Presentation, DDW 2011.
  • Vutien P, Garcia RT, Trinh HN, Nguyen LH, Ha NB, Keeffe EB, Nguyen HA, Nguyen KK, Levitt BS, da Silveira EB, Nguyen MH. HBV precore C1858T mutation does not share similar clinical or virologic characteristics with other precore mutants. Gastroenterology 2011; 140 (Suppl 1): S921-922.
  • Zhang S, Ristau JT, Trinh HN, Garcia RT, Nguyen HA, Levitt BS, Nguyen MH. Treatment of chronic hepatitis B patients according to current guidelines: a community-based study. Gastroenterology 2011; S932.
  • Do AL, Wong CR, Nguyen V, Garcia RT, Trinh HN, Kin KC, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MH. Annual incidence for hepatocellular carcinoma (HCC) in non-cirrhotic patients with chronic hepatitis B (CHB) and cirrhotic patients of all etiologies. Gastroenterology 2011; S920.
  • Ha NB, Trinh HN, Nguyen TT, Klapstein KD, Ha NB, Nguyen MN. Prevalence, risk factors, and disease knowledge of chronic hepatitis B (CHB) infection in Vietnamese Americans in California: A prospective study. Gastroenterology 2010;138:S-631.
  • Do AL, Wong CR, Nguyen V, Garcia RT, Trinh HN, Kin K, Nguyen HA, Nguyen KK, Levitt BS, Nguyen MN. Hepatocellular carcinoma incidence in a cohort of  981 U.S. patients with chronic hepatitis B without cirrhosis and patients with cirrhosis of all etiologies. Gastroenterology 2010;138:S-776.  *Oral presentation, DDW 2010.*
  • Lam KD, Trinh HN, Do ST, Nguyen TT, Garcia RT, Nguyen T, Phan QQ, Nguyen HA, Nguyen KK, Nguyen LH, Nguyen MN. Randomized controlled trial of  pegylated interferon-alpha 2a and ribavirin in patients with treatment-naïve  chronic hepatitis C genotype 6. Gastroenterology 2010;138:S-783. *Oral presentation, DDW 2010.*
  • Nguyen MN, Trinh HN, Do ST, Tran PI, Nguyen TT, Nguyen KK, Nguyen HA, Nguyen NH, Garcia RT. Treatment efficacy of entecavir (ETV) therapy in patients previously treated with adefovir (ADV): Interim report for a multicenter study. Gastroenterology 2010;138:S-793.  *Oral presentation, DDW 2010.*
  • Wong CR, Trinh HN, Garcia RT, Nguyen HA, Nguyen KK, Levitt BS, Ayoub W,  Ahmed A, Keeffe EB, Nguyen MH.  High rate of complete viral suppression with combination therapy with tenofovir using entecavir or lamivudine/emtricitabine in patients with chronic hepatitis B and prior monotherapy failure.  Gastroenterology 2010;138:S-794.  *Oral presentation, DDW 2010.*
  • Nguyen MH, Garcia RT, Trinh HN, Levitt BS, da Silveria EB, Nguyen HA, Nguyen KK, Ahmed A, Keeffe EB.  Hepatitis B-e antigen positive (HBeAg+) chronic hepatitis B (CHB) patients with precore (PC) and basal core promoter (BCP) mutations.  Gastroenterology 2010;138:S-830.
  • Nguyen MH, Trinh HN, Garcia RT, Nguyen HA, Nguyen KK, Levitt BS, da Silveira EB, Ayoub W, Garcia G, Ahmed A, Keeffe EB.  Hepatitis B virus reverse transcriptase mutations were not detected in treatment-naïve patients with chronic hepatitis B using INNO LiPA HBV DR3: a prospective multicenter study.  Gastroenterology 2010; 138:S-830.
  • Nguyen LH, Ko S, Wong SS, Tran P, Trinh HN, Garcia RT, Ahmed A, Lutchman GA, Keeffe EB, Nguyen MH.  Asian ethnicity is a significant predictor for viral dominance by HBV in HBV/HCV co-infected patients: a  multicenter, matched case-control study.  Gastroenterology 2010;138:S-839. *Poster presentation with distinction, DDW 2010*
  • Ha NB, Ha NB, Garcia RT, Trinh HN, Nguyen HA, Nguyen KK, Levitt BS, Chaung KT, Do A, Nguyen MH. Long-Term Outcome of Treatment-Naïve Chronic  Hepatitis B e Antigen-Negative Treated with Entecavir 0.5mg (ETV) or Adefovir 10mg (ADV) in a Real-Life Community Setting. Gastroenterology 2010;138:S-833.
  • Carrie R. Wong, Ruel T. Garcia, Huy N. Trinh, Huy A. Nguyen, Khanh K. Nguyen, Brian S. Levitt, Mindie H. Nguyen.  Poor Adherence to Screening for Hepatocellular Carcinoma (HCC), Especially in Patients with Chronic Hepatitis B (CHB) without Cirrhosis Compared to Patients with Cirrhosis of All Etiologies. Poster presentation, DDW 2009, Chicago.
  • Nghi B. Ha, Nghiem B. Ha, Ruel T. Garcia, Huy N. Trinh, Kenton Wan, Huy A. Nguyen, Khanh K. Nguyen, Brian S. Levitt, Mindie H. Nguyen. Incidences of renal dysfunction in chronic hepatits B (CHB) patients treated with adefovir dipivoxil (ADV) 10 mg.  Poster presentation, DDW 2009, Chicago.
  • Nghi B. Ha, Nghiem B. Ha, Huy N. Trinh, Ruel T. Garcia, Andrew A. Vu, Khanh K. Nguyen, Huy A. Nguyen, Brian S. Levitt, Mindie H. Nguyen. Changes in creatinine clearance (CrC1) in chronic hepatitis B (CHB) patients treated with adefovir dipivoxil (ADV).  Poster presentation, DDW 2009, Chicago.
  • Nghia H. Nguyen, Philip Vutien, Huy N. Trinh, Ruel T. Garcia, Kenton Wan, Huy A. Nguyen, Khanh K. Nguyen, Brian S. Levitt, Mindie H. Nguyen. Treatment Response and Tolerability to Pegylated Interferon (PEG INF) and Ribavirin (RBV) in Treatment-Naïve Asian American Patients with Chronic Hepatitis C and Genotype 1, 2/3 and 6. Oral presentation, DDW 2009, Chicago.
  • Mindie H. Nguyen, Huy N. Trinh, Son T. Do, Thuan T. Nguyen, Phuong L. Tran, Ruel T. Garcia, Nghia H. Nguyen, Huy A. Nguyen, Khanh K. Nguyen. Response to Entecavir (ETV) in Patients with Chronic Hepatitis B (CHB) and Prior Suboptimal Response to Adefovir (ADV): Interim Report of A Multicenter Study. Oral presentation, DDW 2009, Chicago.
  • Nghiem B. Ha, Nghi B. Ha, Ruel T. Garcia, Huy N. Trinh, Andrew A. Vu, Khanh K. Nguyen, Huy A. Nguyen, Brian S. Levitt, Mindie H. Nguyen. Long-Term Outcome of Chronic Hepatitis B Patients Initially Treated with Entecavir in a Real-Life Clinical Setting.  Poster presentation, DDW 2009, Chicago
  • Philip Vutien, Nghia H. Nguyen, Huy N. Trinh, Jiayi Li, Ruel T. Garcia, Carrie R. Wong, Emmet B. Keeffe, Gabriel Garcia, Khanh K. Nguyen, Huy A. Nguyen, Brian S. Levitt, Mindie H. Nguyen.  Response to Peginterferon (PEG IFN) and Ribavirin (RBV) in Asian Americans and Non-Asian Americans with Chronic Hepatitis C (CHC) in a Real-Life Community Setting: a Multi-center Study.  Poster presentation, DDW 2009, Chicago
  • Nghiem B. Ha, Nghi B. Ha, Ruel T. Garcia, Huy N. Trinh, Huy A. Nguyen, Khanh K. Nguyen, Mindie H. Nguyen.  Long-term Outcome at Year 5 in Chronic Hepatitis B (CHB) Patients Initially Treated with adefovir dipivoxil (ADV) in a Real-Life Clinical Setting.  Poster presentation, DDW 2009, Chicago
  • Philip Vutien, Nghia H. Nguyen, Huy N. Trinh, Jiayi Li, Ruel T. Garcia, Carrie R. Wong, Emmet B. Keeffe, Gabriel Garcia, Khanh K. Nguyen, Huy A. Nguyen, Brian S. Levitt, Mindie H. Nguyen.  Response to Peginterferon (PEG IFN) and Ribavirin (RBV) in Asian Americans and Non-Asian Americans with Chronic Hepatitis C (CHC) in a Real-Life Community Setting: A Multi-Center Study.  Poster presentation, DDW 2009, Chicago
  • Nghi B. Ha, Nghiem B. ha, Huy N. Trinh, Ruel T. Garcia, Whitney de Luna, Khanh K. Nguyen, Huy A. Nguyen, Brian S. Levitt, Mindie H. Nguyen. Changes in Creatinine Clearance in chronic hepatitis B patients treated with Adefovir Dipivoxil. Poster 901; AASLD Annual Meeting, San Francisco, October 2008.
  • Mindie H. Ngyen, Huy N. Trinh, Ruel T. Garcia, Long H. Nguyen, Huy A. Nguyen, Khanh K. Nguyen, Brian S. Levitt. Treatment Outcomes in patients with chronichHepatitis B and partial response to Adefovir who were switched to Entecavir (ETV).  Poster 904; AASLD Annual Meeting, San Francisco, October 2008.
  • Samuel S.Lee, E. Jenny Healthcote, William Sievert, Huy N. Trinh, Kelly D. Kaita, Zobair M. Younoss, Jacob George, Mitchell Shiffman, Patrick Marcellin, Jeff Sorbel, Jane Anderosn, Elsa Mondou, Joe Quinn, Franck Rousseau. Tenofovir Disoproxil Fumarate (TDF) versus Adefovir Dipivoxil (ADV) in Asians with HBEAG positive and BHEAG-negative chronic hepatitis B participating in Studies 102 and 103. Poster 980; AASLD Annual Meeting, San Francisco, October 2008.
  • Phillip Vutien, Nghia H. Nguyen, Ruel T. Garcia, Huy N. Trinh, Long H Nguyen, Emmet B Keffe, Gabriel Garcia, Khanh K Nguyen, Huy A Nguyen, Brian S Levitt, Mindie H Nguyen. Poster 1273; AASLD Annual Meeting, San Francisco, October 2008.
  • E. Jenny Healthcote, Patrick Marcellin, Ira M. Jacobson, Mitchell L. Shiffman, Huy N. Trinh, Keeenth J. Peschell, Diane Goodwin, Jeff Sorbel, Elizabeth A. Fagan, Franck Rousseau. Limited Value of SingleALT Determination for Assessing Chronic Hepatitis B. Poster 850, AASLD Annual Meeting, San Francisco, October 2008.
  • Mindie Nguyen, Huy N. Trinh, Ruel T. Garcia, Long Nguyen, Vutien Philip, Nghiem Ha, Huy A. Nguyen, Khanh Nguyen, Emmet Keeffe, Nghi Ha.  Prevalence of HBV DNA polymerase (B-DNA pol) mutations in 345 patients with treatment-naïve chronic hepatitis B.  Poster, AGA, Annual Meeting, San Diego, May 2008.
  • Long Nguyen, Nghiem Ha, Vutien Philip, Nghi Ha, Ruel Garcia, Huy N. Trinh, Huy A. Nguyen, Khanh Nguyen, Brian Levitt, Emmet Keeffe, Mindie Nguyen.  Vietnamese patients with chronic hepatitis B exhibit different viral genotype distributions than Chinese patients. Poster, AGA, Annual Meeting, San Diego, May 2008.
  • Mindie Nguyen, Huy N. Trinh, Ruel T. Garcia, Long Nguyen, Nghiem Ha, Philip Vutien, Huy A. Nguyen, Khanh K. Nguyen, Emmet Keeffe. Almost half of the chronic hepatitis B (CHB) patients with positive HBeAg have confirmed precore and/or basal core promoter (preC/BCP) mutations. Poster, AGA, Annual Meeting, San Diego, May 2008.
  • Mindie Nguyen, Huy N. Trinh, Ruel T. Garcia, Jeannine Phan, Nghiem Ha, Gerald Weiss, Khanh K. Nguyen, Huy A. Nguyen, Emmet B. Keeffe.  Age >35 years is a predictor of significant histology in chronic hepatitis B (CHB) patients with normal ALT even with stricter cut-offs (<30 for men and <19 for women). Poster, AGA, Annual Meeting, San Diego, May 2008.
  • Mindie H. Nguyen, Huy N. Trinh, Ruel T. Garcia, Jeanine Phan, Gloria Nguyen, Gerald Weiss, Huy Nguyen, Khanh Nguyen, Emmet B. Keeffe.  High Prevalence of significant histology disease in patients with chronic hepatitis B and normal ALT.  Poster, AASLD Annual Meeting, Boston, October 2007.
  • Mindie H. Nguyen, Huy N. Trinh, Ruel T. Garcia, Jeanine Phan, Gloria Nguyen, Gerald Weiss, Huy Nguyen, Khanh Nguyen, Emmet B. Keeffe.  Very high prevalence of chronic hepatitis B with  mixed wild-type and precore/core promoter mutant virus, especially among older patients. Poster, AASLD Annual Meeting, Boston, October 2007.
  • Mindie H. Nguyen, Huy N. Trinh, Ruel T. Garcia.  Significant histologic disease in HBV-infected patients with normal to minimally elevated ALT levels at initial evaluation [Abstract].  AASLD Annual Meeting, San Francisco, October 2005.
  • Mindie H. Nguyen, Huy N. Trinh, Ruel T. Garcia, Emmet B. Keeffe.  Treatment outcomes to combination therapy in patients with HCV genotype 6 [Abstract].  AASLD Annual Meeting, San Francisco, October 2005.
  • Khoa D. Lam, Mindie H Nguyen, Huy N Trinh, Long Nguyen, Khanh K Ngyen, Huy A Nguyen, Aijaz Ahmed, Ruel T Garcia.  Dimunitive colon polyps in Asians are more likely to be adenomatous compared to non-Asians [Abstract]. American College of Gastroenterology Annual Meeting, Honolulu, November 2005.
  • Ruel T Garcia, Khoa D Lam, Huy N. Trinh, Khanh K. Nguyen, Long Nguyen, Huy A. Nguyen, Mindie H. Nguyen.  Outcomes of screening colonoscopy in Asian Americans compared to other ethnic groups [Poster].  American College of Gastrotenterology Annual Meeting, Honolulu, November 2005.
  • Long Nguyen, Khoa D. Lam, Mindie H. Nguyen, Huy N Trinh, Khanh K Nguyen, Huy A Nguyen and Ruel T Garcia.  Outcomes of colonoscopic evaluation for rectal bleed in Asian Americans [Poster].  American College of Gastroenterology Annual Meeting, Honolulu, November 2005.
  • Nguyen MH, Trinh HN, Garcia RT, Ning J, Keeffe EB.  High prevalence of novel genotypes in Vietnamese patients with hepatitis C [Abstract].  Gastroenterology 2004;126:4(suppl. 2):2020A
  • Nguyen MH, Trinh HN, Garcia RT, Ning J, Keeffe EB.  Evaluation and outcomes of combination therapy with interferon or pegylated interferon and ribavirin in a cohort of 67 Southeast Asian patients with hepatitis C genotypes 6, 7, 8, and 9 [Abstract]. Hepatology 2003;38:4(suppl. 1): 1014A.
  • Nguyen MH, Trinh HN, Garcia RT, Vien P, Keeffe EB.  Hepatitis C is a major etiology for HCC in Vietnamese Americans.  submitted to AASLD Annual Meeting, Boston, October 2004.  Am J Gastroenterol 2004.  In press.

Bác sĩ Trịnh Ngọc Huy